⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
Nation provides global access to innovation
prnewswire.com
MRK
Global Single-use Bioreactors Market Forecast to Surge from USD 3.61 Billion in 2025 to USD 15.11 Billion by 2034
globenewswire.com
TMO
MRK
AVTR
RGEN
GLW
Pharma Predictive Analytics Market Soars to $9.37 Billion by 2031 with 28.42% CAGR Growth
globenewswire.com
NVDA
MRK
IBM
ORCL
Global Sterile Bioprocess Filtration Market Set to Surge, Projected to Reach USD 31.33 Billion by 2034
globenewswire.com
TMO
MRK
RGEN
PCAR
GEHC
Global TROP-2 Targeted Therapy Market Set to Reach USD 3.29 Billion by 2031 with an 8.6% CAGR
globenewswire.com
GILD
AZN
PFE
MRK
BMY
BIIB
BNTX
Tumor Microenvironment Modulation Market to Hit USD 3.73 Billion by 2031 with a 7.4% CAGR - Key Trends and Insights
globenewswire.com
BMY
MRK
AZN
PFE
REGN
GILD
AMGN
BE
LLY
IOVA
NVS
Global Single Use Downstream Bioprocessing Market to Surpass USD 12.15 Billion by 2035: Key Growth Drivers, Challenges, and Trends
globenewswire.com
TMO
MRK
Global Cancer Biologics Market Poised to Reach USD 189 Billion by 2035 with a CAGR of 8.9%
globenewswire.com
ABT
ABBV
AMGN
AZN
BNTX
BMY
LLY
GILD
JNJ
MRK
NVS
PFE
SNY
TAK
Non-Small Cell Lung Cancer Market Poised for Robust Expansion at a 6.6% CAGR Through 2036, Driven by Emerging Targeted and Immunotherapy Innovations | DelveInsight
prnewswire.com
PFE
ABBV
RMD
GSK
AZN
BNTX
INCY
IOVA
RGEN
MRK
LLY
IBIO
GILD
AMGN
JNJ
NVS
RIGL
BIIB
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s divarasib shows superiority in head-to-head phase III trial against approved KRAS G12C inhibitors in non-small cell lung cancer
globenewswire.com
AMGN
MRK